Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-17.05M
↓ 95% below average
Average (8y)
$-8.74M
Historical baseline
Range
High:$-1.63M
Low:$-17.05M
CAGR
+3.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-17.05M | -444.8% |
| 2023 | $-3.13M | -37.8% |
| 2022 | $-2.27M | -39.2% |
| 2021 | $-1.63M | +84.3% |
| 2020 | $-10.41M | +17.1% |
| 2019 | $-12.56M | -20.2% |
| 2018 | $-10.45M | -24.1% |
| 2017 | $-8.42M | +33.9% |
| 2016 | $-12.74M | - |